📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Safety and immunogenicity of ChAdOx1 85A prime followed by MVA85A boost compared with BCG revaccination among Ugandan adolescents who received BCG at birth: a randomised, open-label trial. (2024)

First Author: Wajja A

Attributed to: Immunomodulation and Vaccines funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s1473-3099(23)00501-7

PubMed Identifier: 38012890

Publication URI: http://europepmc.org/abstract/MED/38012890

Type: Journal Article/Review

Volume: 24

Parent Publication: The Lancet. Infectious diseases

Issue: 3

ISSN: 1473-3099